BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15546496)

  • 1. The use of microbubbles to target drug delivery.
    Tsutsui JM; Xie F; Porter RT
    Cardiovasc Ultrasound; 2004 Nov; 2():23. PubMed ID: 15546496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery.
    Ferrara K; Pollard R; Borden M
    Annu Rev Biomed Eng; 2007; 9():415-47. PubMed ID: 17651012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives.
    Panje CM; Wang DS; Willmann JK
    Invest Radiol; 2013 Nov; 48(11):755-69. PubMed ID: 23697924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic gene and drug delivery to the cardiovascular system.
    Mayer CR; Bekeredjian R
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1177-92. PubMed ID: 18474407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model.
    Xie F; Boska MD; Lof J; Uberti MG; Tsutsui JM; Porter TR
    Ultrasound Med Biol; 2008 Dec; 34(12):2028-34. PubMed ID: 18692294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives.
    Geis NA; Katus HA; Bekeredjian R
    Curr Pharm Des; 2012; 18(15):2166-83. PubMed ID: 22352771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound, microbubbles and the blood-brain barrier.
    Meairs S; Alonso A
    Prog Biophys Mol Biol; 2007; 93(1-3):354-62. PubMed ID: 16959303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro- and nanobubbles: a versatile non-viral platform for gene delivery.
    Cavalli R; Bisazza A; Lembo D
    Int J Pharm; 2013 Nov; 456(2):437-45. PubMed ID: 24008081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle.
    Leong-Poi H; Kuliszewski MA; Lekas M; Sibbald M; Teichert-Kuliszewska K; Klibanov AL; Stewart DJ; Lindner JR
    Circ Res; 2007 Aug; 101(3):295-303. PubMed ID: 17585071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of lipid-coated microbubbles.
    Unger EC; Porter T; Culp W; Labell R; Matsunaga T; Zutshi R
    Adv Drug Deliv Rev; 2004 May; 56(9):1291-314. PubMed ID: 15109770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ultrasound in drug delivery systems: emphasis on experimental methodology and mechanisms.
    Feril LB; Tachibana K
    Int J Hyperthermia; 2012; 28(4):282-9. PubMed ID: 22621730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonoporation: mechanistic insights and ongoing challenges for gene transfer.
    Delalande A; Kotopoulis S; Postema M; Midoux P; Pichon C
    Gene; 2013 Aug; 525(2):191-9. PubMed ID: 23566843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbubble stability is a major determinant of the efficiency of ultrasound and microbubble mediated in vivo gene transfer.
    Alter J; Sennoga CA; Lopes DM; Eckersley RJ; Wells DJ
    Ultrasound Med Biol; 2009 Jun; 35(6):976-84. PubMed ID: 19285783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery.
    Liu Y; Miyoshi H; Nakamura M
    J Control Release; 2006 Aug; 114(1):89-99. PubMed ID: 16824637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles.
    Suzuki R; Oda Y; Utoguchi N; Maruyama K
    J Control Release; 2011 Jan; 149(1):36-41. PubMed ID: 20470839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbubbles as ultrasound triggered drug carriers.
    Tinkov S; Bekeredjian R; Winter G; Coester C
    J Pharm Sci; 2009 Jun; 98(6):1935-61. PubMed ID: 18979536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound targeted microbubble destruction for drug and gene delivery.
    Mayer CR; Geis NA; Katus HA; Bekeredjian R
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1121-38. PubMed ID: 18817517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles.
    Mannell H; Pircher J; Fochler F; Stampnik Y; Räthel T; Gleich B; Plank C; Mykhaylyk O; Dahmani C; Wörnle M; Ribeiro A; Pohl U; Krötz F
    Nanomedicine; 2012 Nov; 8(8):1309-18. PubMed ID: 22480917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability.
    Geis NA; Mayer CR; Kroll RD; Hardt SE; Katus HA; Bekeredjian R
    Ultrasound Med Biol; 2009 Jul; 35(7):1119-26. PubMed ID: 19427103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques.
    Zhang Q; Wang Z; Ran H; Fu X; Li X; Zheng Y; Peng M; Chen M; Schutt CE
    Acad Radiol; 2006 Mar; 13(3):363-7. PubMed ID: 16488849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.